F. Piñero,I. Boin,A. Chagas,E. Quiñonez,S. Marciano,M. Vilatobá,L. Santos,M. Anders,S. Hoyos Duque,A. Soares Lima,J. Menendez,M. Padilla,J. Poniachik,R. Zapata,M. Maraschio,R. Chong Menéndez,L. Muñoz,D. Arufe,R. Figueroa,M. Mendizabal,S. Hurtado Gomez,R. Stucchi,C. Maccali,R. Vergara Sandoval,C. Bermudez,L. McCormack,A. Varón,A. Gadano,J. Mattera,F. Rubinstein,F. Carrilho and M. Silva. Direct-Acting Antivirals and Hepatocellular Carcinoma: No Evidence of Higher Wait-List Progression or Posttransplant Recurrence. Liver Transpl. 2020;26(5):10.1002/lt.25744.
